Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

Francesca Bandinelli,1 Francesco Scazzariello,1 Emanuela Pimenta da Fonseca,2 Mittermayer Barreto Santiago,2 Claudio Marcassa,3 Francesca Nacci,1 Marco Matucci Cerinic1 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 2Service of Rheumatology, Hospital San...

Full description

Bibliographic Details
Main Authors: Bandinelli F, Scazzariello F, Pimenta da Fonseca E, Barreto Santiago M, Marcassa C, Nacci F, Matucci Cerinic M
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:Drug Design, Development and Therapy
Subjects:
spondyloarthritis
morning stiffness
glucocorticoids
modified-release prednisone
Online Access:https://www.dovepress.com/low-dose-modified-release-prednisone-in-axial-spondyloarthritis-3-mont-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/low-dose-modified-release-prednisone-in-axial-spondyloarthritis-3-mont-peer-reviewed-article-DDDT

Similar Items